Page last updated: 2024-10-30

loratadine and Febrile Neutropenia

loratadine has been researched along with Febrile Neutropenia in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.

Research Excerpts

ExcerptRelevanceReference
"Type of cancer, treatment, age, and BMI were not significant predictors of bone pain."1.46Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade. ( Abrams, M; Gavioli, E, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gavioli, E1
Abrams, M1

Other Studies

1 other study available for loratadine and Febrile Neutropenia

ArticleYear
Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3

    Topics: Aged; Antineoplastic Agents; Bone Diseases; Cohort Studies; Famotidine; Febrile Neutropenia; Female;

2017